ING Groep NV Raises Stake in HCA Healthcare, Inc. (NYSE:HCA)

ING Groep NV lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 267.3% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 49,201 shares of the company’s stock after purchasing an additional 35,807 shares during the quarter. ING Groep NV’s holdings in HCA Healthcare were worth $19,997,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its holdings in HCA Healthcare by 0.4% in the first quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock valued at $5,666,569,000 after purchasing an additional 60,304 shares during the period. Capital World Investors raised its position in shares of HCA Healthcare by 57.5% in the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after buying an additional 1,019,750 shares during the period. Darsana Capital Partners LP increased its stake in HCA Healthcare by 53.3% during the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after acquiring an additional 400,000 shares during the last quarter. TD Asset Management Inc increased its position in HCA Healthcare by 2.7% during the 2nd quarter. TD Asset Management Inc now owns 741,130 shares of the company’s stock worth $238,110,000 after purchasing an additional 19,812 shares in the last quarter. Finally, Epoch Investment Partners Inc. raised its stake in shares of HCA Healthcare by 16.4% in the 2nd quarter. Epoch Investment Partners Inc. now owns 631,854 shares of the company’s stock valued at $203,002,000 after acquiring an additional 88,948 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts have commented on the company. Wells Fargo & Company raised their price objective on HCA Healthcare from $395.00 to $400.00 and gave the company an “equal weight” rating in a research report on Wednesday, November 6th. TD Cowen lowered their price objective on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Royal Bank of Canada increased their price target on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. Truist Financial increased their target price on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Finally, KeyCorp lowered their target price on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a report on Monday, October 28th. Five research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $385.00.

HCA Healthcare Stock Performance

Shares of HCA opened at $345.36 on Friday. The stock has a market capitalization of $87.48 billion, a P/E ratio of 15.51, a P/E/G ratio of 1.34 and a beta of 1.68. HCA Healthcare, Inc. has a 12-month low of $237.57 and a 12-month high of $417.14. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The firm’s 50 day moving average is $387.05 and its 200-day moving average is $357.11.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.76%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio is 11.85%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The trade was a 21.97 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,155 shares of company stock valued at $5,608,990. 1.60% of the stock is currently owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.